These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 32543359

  • 1. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V, De P, Ojha PK, Saha A, Roy K.
    Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
    [Abstract] [Full Text] [Related]

  • 2. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
    Kumar V, Saha A, Roy K.
    Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088
    [Abstract] [Full Text] [Related]

  • 3. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I, Melkemi N, Salah T, Ghalem S.
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746
    [Abstract] [Full Text] [Related]

  • 5. Exploring 2D-QSAR for prediction of beta-secretase 1 (BACE1) inhibitory activity against Alzheimer's disease.
    Kumar V, Ojha PK, Saha A, Roy K.
    SAR QSAR Environ Res; 2020 Feb 26; 31(2):87-133. PubMed ID: 31865778
    [Abstract] [Full Text] [Related]

  • 6. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB, Aguan K, Mitra S, Bhattacharjee A.
    J Biomol Struct Dyn; 2017 Jun 26; 35(8):1729-1742. PubMed ID: 27410776
    [Abstract] [Full Text] [Related]

  • 7. A modified binary particle swarm optimization with a machine learning algorithm and molecular docking for QSAR modelling of cholinesterase inhibitors.
    Shamsi E, Rahati A, Dehghanian E.
    SAR QSAR Environ Res; 2021 Sep 26; 32(9):745-767. PubMed ID: 34494463
    [Abstract] [Full Text] [Related]

  • 8. Cheminformatic modelling of β-amyloid aggregation inhibitory activity against Alzheimer's disease.
    Kumar V, Ojha PK, Saha A, Roy K.
    Comput Biol Med; 2020 Mar 26; 118():103658. PubMed ID: 32174326
    [Abstract] [Full Text] [Related]

  • 9. Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors.
    Ahmadi S, Ganji S.
    Curr Drug Discov Technol; 2016 Mar 26; 13(4):232-253. PubMed ID: 27457492
    [Abstract] [Full Text] [Related]

  • 10. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
    Manouchehrizadeh E, Mostoufi A, Tahanpesar E, Fereidoonnezhad M.
    Comput Biol Chem; 2019 Jun 26; 80():463-471. PubMed ID: 31170562
    [Abstract] [Full Text] [Related]

  • 11. Quantitative Structure-Activity Relationship Modeling of Pea Protein-Derived Acetylcholinesterase and Butyrylcholinesterase Inhibitory Peptides.
    Asen ND, Udenigwe CC, Aluko RE.
    J Agric Food Chem; 2023 Nov 01; 71(43):16323-16330. PubMed ID: 37856319
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.
    Kamal MA, Shakil S, Nawaz MS, Yu QS, Tweedie D, Tan Y, Qu X, Greig NH.
    CNS Neurol Disord Drug Targets; 2017 Nov 01; 16(7):820-827. PubMed ID: 28176640
    [Abstract] [Full Text] [Related]

  • 13. Receptor-based modeling and 3D-QSAR for a quantitative production of the butyrylcholinesterase inhibitors based on genetic algorithm.
    Zaheer-ul H, Uddin R, Yuan H, Petukhov PA, Choudhary MI, Madura JD.
    J Chem Inf Model; 2008 May 01; 48(5):1092-103. PubMed ID: 18444627
    [Abstract] [Full Text] [Related]

  • 14. Multi-combined QSAR, molecular docking, molecular dynamics simulation, and ADMET of Flavonoid derivatives as potent cholinesterase inhibitors.
    Soufi H, Moussaoui M, Baammi S, Baassi M, Salah M, Daoud R, El Allali A, Belghiti ME, Moutaabbid M, Belaaouad S.
    J Biomol Struct Dyn; 2024 Aug 01; 42(12):6027-6041. PubMed ID: 37485860
    [Abstract] [Full Text] [Related]

  • 15. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS, Khan MI, Alharbi AH, Ahmad V, Yadav BS.
    Nutrients; 2023 Mar 24; 15(7):. PubMed ID: 37049419
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloid β-induced cytotoxicity.
    Bukhari SN, Jantan I, Masand VH, Mahajan DT, Sher M, Naeem-ul-Hassan M, Amjad MW.
    Eur J Med Chem; 2014 Aug 18; 83():355-65. PubMed ID: 24980117
    [Abstract] [Full Text] [Related]

  • 17. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA, Ojo AB, Okolie C, Nwakama MC, Iyobhebhe M, Evbuomwan IO, Nwonuma CO, Maimako RF, Adegboyega AE, Taiwo OA, Alsharif KF, Batiha GE.
    Molecules; 2021 Apr 01; 26(7):. PubMed ID: 33915968
    [Abstract] [Full Text] [Related]

  • 18. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.
    Deb PK, Sharma A, Piplani P, Akkinepally RR.
    Mol Divers; 2012 Nov 01; 16(4):803-23. PubMed ID: 22996404
    [Abstract] [Full Text] [Related]

  • 19. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC, Qiu GL, Li B, Shi JB, Liu XH, Tang WJ.
    Eur J Med Chem; 2018 Mar 10; 147():194-204. PubMed ID: 29438888
    [Abstract] [Full Text] [Related]

  • 20. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM, Feng B, Fu H, Liu AL, Wang L, Du GH, Wu S.
    Molecules; 2017 Jan 20; 22(1):. PubMed ID: 28117700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.